MR编号 | AT/H/1114/001 |
---|
药品名称 | Noradrenaline Kabi 1 mg/ml concentrate for solution for infusion |
---|
活性成分 | - Norepinephrine tartrate 1.0 mg/ml
|
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Fresenius Kabi Austria GmbH
Hafnerstraße 36
8055 Graz
Austria |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - Belgium (BE)
Noradrenaline Kabi 1 mg/ml concentraat voor oplossing voor infusie - Latvia (LV)
Norepinephrine Kabi 1 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Netherlands (NL)
- Lithuania (LT)
Norepinephrine Kabi 1 mg/ml koncentratas infuziniam tirpalui - Ireland (IE)
- Estonia (EE)
- Hungary (HU)
- Spain (ES)
- Cyprus (CY)
Noradrenaline/Kabi 1mg/ml concentrate for solution for infusion - Portugal (PT)
- Czechia (CZ)
Noradrenalin Fresenius Kabi - Romania (RO)
- Greece (GR)
- Slovakia (SK)
Norepinephrine Kabi 1 mg/ml - Sweden (SE)
- Slovenia (SI)
Noradrenalin Kabi 1 mg/ml koncentrat za raztopino za infundiranje - Norway (NO)
Noradrenalin Fresenius Kabi - Croatia (HR)
Noradrenalin Kabi 1 mg/ml koncentrat za otopinu za infuziju - Germany (DE)
Noradrenaline Kabi 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Finland (FI)
- United Kingdom (Northern Ireland) (XI)
- Denmark (DK)
- Poland (PL)
Noradrenaline Kabi
|
---|
许可日期 | 2021/03/19 |
---|
最近更新日期 | 2024/11/08 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|